证券代码：000070 证券简称：ST特信 公告编号：2025-31 深圳市特发信息股份有限公司 关于对深圳证券交易所2024年年报问询函回复的公告 本公司及董事会全体成员保证信息披露的内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 深圳市特发信息股份有限公司（以下简称"公司"或"特 发信息"）于近日收到深圳证券交易所上市公司管理二部下 发的《关于对深圳市特发信息股份有限公司 2024 年年报的 问询函》（公司部年报问询函〔2025〕401 号）（以下简称 "问询函"）。根据问询函的要求，公司及年报审计会计师 事务所对问询函中的问题进行了认真核查，现就相关问题回 复如下： 问题一： 《深圳证券交易所股票上市规则（2024 年修订）》第 9.8.8 条规定，"上市公司因触及本规则第 9.8.1 条第八项 情形，其股票交易被实施其他风险警示后，同时符合下列条 件的，可以向本所申请对其股票交易撤销其他风险警示：（一） 公司已就行政处罚决定所涉事项对相应年度财务会计报告 进行追溯重述；（二）自中国证监会作出行政处罚决定书之 日起已满十二个月"。请结合前述规定及你公司整改情况， 3.公司不存在被实施其他风 ...

证券代码：000070 证券简称：ST特信 公告编号：2025-30 深圳市特发信息股份有限公司 关于撤销其他风险警示暨停复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、深圳市特发信息股份有限公司（以下简称"公司"） 股票交易自 2025 年 7 月 8 日（星期二）开市起停牌一天， 并于 2025 年 7 月 9 日（星期三）开市起复牌。 2、公司股票自 2025 年 7 月 9 日（星期三）开市起撤销 其他风险警示，证券简称由"ST 特信"变更为"特发信息"； 股票代码不变，仍为"000070"，股票交易日涨跌幅限制由 5%变为 10%。 一、股票种类、简称、证券代码以及股票停复牌起始日 1、股票种类：人民币普通股 A 股 2、股票简称：由"ST 特信"变更为"特发信息" 3、股票代码：000070 4、撤销其他风险警示的起始日：2025 年 7 月 9 日 5、公司股票停复牌起始日：2025 年 7 月 8 日开市起停 牌、2025 年 7 月 9 日开市起复牌。 制由 5%变为 10%。 二、公司股票被实施其他风险警示的情况 ...

Core Viewpoint - The company, as a national high-tech enterprise, is actively transforming its development model by focusing on high-quality projects in the information technology sector, aligning with national strategies for manufacturing and digital development [1][2]. Group 1: Corporate Reform and Strategy - The company emphasizes the integration of party leadership and corporate governance, implementing a governance model that enhances strategic decision-making and operational management [2]. - The strategic layout includes a focus on new generation information technology, with a dual approach of "products + services" and a diversified ecosystem comprising four major sectors: cables, smart services, integrated industries, and property leasing [2][4]. Group 2: Technological Innovation - The company has established a comprehensive innovation system, with numerous technology centers and nearly 600 valid patents, showcasing its technological strength [3]. - Significant breakthroughs have been achieved in key technology areas such as hollow-core optical fibers and special optical cables, contributing to advancements in the optical communication industry [3]. Group 3: Industry Layout and Growth - The cable sector is positioned as a backbone in the optical fiber and cable industry, capitalizing on opportunities from national network construction and new power systems [4][5]. - The smart services sector aims to create a new ecosystem for smart cities, providing integrated solutions from planning to operation [5]. - The integration sector focuses on high-performance computing and embedded systems, driving deep technological convergence [5][6]. - The property leasing sector leverages prime assets in Shenzhen to develop high-quality industrial parks, enhancing the business environment for tech companies [5][6]. Group 4: Collaborative Development - The company promotes a collaborative development model across its various sectors, ensuring mutual benefits and resilience against market fluctuations [6]. - The ongoing commitment to reform and innovation positions the company to seize strategic opportunities in the Guangdong-Hong Kong-Macao Greater Bay Area [6].

Core Viewpoint - ST Te Xin (000070.SZ) has announced that it will apply to the Shenzhen Stock Exchange to revoke the "other risk warning" on its stock, as the factors leading to the warning have been eliminated and it has completed the necessary rectifications [2][4][6] Financial Performance - In 2024, the company reported revenue of 4.409 billion yuan, a year-on-year decrease of 10.69%, and a net loss attributable to shareholders of 403 million yuan, down 47.74% year-on-year [4] - The decline in profit is primarily due to underperformance in the market expansion of acquired subsidiaries and the smart city project, leading to impairment provisions for goodwill and related assets [4] - Despite the overall profit decline, the cable segment achieved revenue of 2.931 billion yuan, a year-on-year increase of 6.25%, indicating competitiveness and stability in this segment [4] - The integration segment reported revenue of 380 million yuan, a year-on-year increase of 19.61%, highlighting growth potential [4] Regulatory Issues - The company faced scrutiny due to financial fraud, with its subsidiary overstating profits by 149 million yuan over five years, leading to administrative penalties and a warning from the Shenzhen Stock Exchange [3][4] - Following the penalties, the company's stock was labeled "ST Te Xin," resulting in nine consecutive trading days of declines [3] Future Outlook - If the application to revoke the risk warning is successful, it will signify the completion of necessary rectifications and present new opportunities for the company [6] - The company is expected to face challenges in enhancing profitability and market image, necessitating transparent information disclosure and strong performance to rebuild its reputation [6] - The industry is becoming increasingly competitive, prompting the company to accelerate its transformation and optimize its business structure to improve profitability [6]

Group 1 - Shengde Xintai won a bid for a thermal power steel pipe project worth approximately 217 million yuan, accounting for 8.15% of its audited revenue for 2024 [1] - High-speed Electric's subsidiary won a project for the Shanghai-Nanjing-Hefei high-speed railway, with a bid amount of 71.76 million yuan [1] - Cangge Mining's subsidiary received a construction permit for a lithium-boron mining project, with a construction area of 106,900 square meters [2] Group 2 - China Electric Power Construction signed a mining transportation project contract in Guinea worth approximately 5.063 billion yuan, with a total duration of about 72 months [3] - Guobang Pharmaceutical's subsidiary completed the registration of an equity investment fund focusing on strategic emerging industries [4] - Deshi Co. obtained two invention patents related to oil and gas field development [5][26] Group 3 - Xue Tian Salt Industry expects a significant decrease in net profit for the first half of 2025, projecting a decline of 76.34% to 80.29% [6] - Rundu Co. received a drug registration certificate for moxifloxacin hydrochloride tablets, used for treating various bacterial infections [7] - China Nuclear Power reported a 15.65% increase in power generation in the first half of the year, with nuclear power generation up by 12.01% [8] Group 4 - Suqian Liansheng obtained two invention patents related to wastewater treatment methods [9] - Boshi Co. signed a 109 million yuan operation and maintenance service contract for solid product packaging [11] - *ST Sailong's subsidiary received a drug registration certificate for torasemide injection, used for various medical conditions [13] Group 5 - North Bay Port reported a 10.95% increase in cargo throughput for the first half of 2025, with container throughput also showing growth [14] - Kaiwei Te expects a revenue increase of 56.17% to 90.87% for the first half of 2025 [15] - Wankai New Materials plans to reduce production and conduct maintenance on 60,000 tons of PET capacity, affecting overall performance [16] Group 6 - Haiwang Bio's HW130 injection successfully completed Phase I clinical trials, showing good safety and tolerability [19] - Zhenai Meijia received a total of 22.8 million yuan in compensation for land acquisition, which will significantly impact its 2025 performance [20] - Changyuan Electric reported a 23.58% decrease in power generation in June, with a notable decline in thermal power generation [21] Group 7 - Shouxiangu's subsidiary completed the registration of two health food products [22] - Kailun Co. announced the resignation of its deputy general manager and board secretary [23] - Xibu Muye reported a 2.15% year-on-year increase in fresh milk production in June [24] Group 8 - Deshi Co. obtained two invention patents related to oil and gas field development [26] - Jingwei Huikai plans to acquire a 12.44% stake in Nuo Si Micro for 149 million yuan [27] - Electric Alloy completed the registration of its subsidiary in Mexico [29] Group 9 - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025 [30] - Guizhou Moutai repurchased approximately 3.38 million shares, accounting for 0.2692% of its total share capital [31][32] - Warner Pharmaceutical received approval for the listing application of a raw material drug for treating respiratory diseases [34] Group 10 - Yuan Dong Bio's independent director is under investigation for serious violations [35] - Dash Intelligent signed a contract for a smart project worth 11.88 million yuan [36] - Dayou Energy plans to transfer 586,500 tons of coal production capacity replacement indicators [37] Group 11 - Foton Motor reported a 150.96% increase in new energy vehicle sales in the first half of 2025 [39] - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [40] - Zongshen Power expects a net profit increase of 70% to 100% for the first half of 2025 [42] Group 12 - Yingboer plans to sell its wholly-owned subsidiary for 239 million yuan [44] - Changan Automobile reported a 1.59% increase in total vehicle sales in the first half of 2025 [46] - Fulian Precision signed a cooperation framework agreement with Sichuan Development Longmang [48] Group 13 - Nengte Technology plans to repurchase shares worth 300 million to 500 million yuan [50] - Longsoft Technology's controlling shareholder donated 3.43% of the company's shares [51] - Data Port's shareholders plan to reduce their holdings by up to 2% [52]

Core Viewpoint - ST Te Xin (000070.SZ) has announced that it will apply to the Shenzhen Stock Exchange to lift the risk warning on its stock after rectifying issues related to an administrative penalty and adequately provisioning for investor claims [2][6]. Financial Reporting and Penalties - The company has restated its financial reports for the relevant years due to administrative penalties related to financial fraud, which resulted in a cumulative profit inflation of 149 million yuan over five years [3][5]. - Following the fraud incident, the company was designated as "ST Te Xin," leading to a 70% drop in market value as the stock faced nine consecutive trading halts [5]. - The Shenzhen Securities Regulatory Bureau imposed a fine of 8 million yuan on the company and fines ranging from 1 million to 4 million yuan on several former executives, with some facing market bans of up to 10 years [5][6]. Performance and Recovery Efforts - In 2024, the company reported revenues of 4.409 billion yuan, a year-on-year decline of 10.69%, and a net loss of 403 million yuan, a decrease of 47.74% [6]. - Despite the overall decline, the cable segment achieved revenues of 2.931 billion yuan, a year-on-year increase of 6.25%, indicating competitive strength [6]. - The company plans to focus on AI computing power, low-altitude economy drones, and military information technology in its future development strategy [6]. Challenges Ahead - The company faces challenges in rebuilding investor trust, which requires time and consistent, transparent information disclosure [7]. - Increasing industry competition necessitates a transformation in business structure and improvement in profitability [7].

证券代码：000070 证券简称：ST特信 公告编号：2025-29 的《行政处罚决定书》（〔2024〕9 号）后于 2024 年 7 月 6 日对外披露了《关于收到行政处罚决定书的公告》（公告编 号：2024-38）。 深圳市特发信息股份有限公司 董事会第九届十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 深圳市特发信息股份有限公司（以下简称公司）董事会 于 2025 年 7 月 1 日以通讯方式召开第九届十五次会议。公 司于 2025 年 6 月 25 日以书面方式发出会议通知。应参加表 决的董事 9 人，实际参加表决的董事 9 人。会议通知、议案 及相关资料已按照规定的时间与方式送达全体董事、监事。 本次会议的召开符合《公司法》、本公司《章程》和《董事 会议事规则》。会议对以下议案作出决议： 一、审议通过《关于深圳市特发信息股份有限公司申请 撤销其他风险警示的议案》 董事会同意公司于 2025 年 7 月 7 日向深圳证券交易所 申请撤销股票交易其他风险警示。具体情况如下： （一）公司股票被实施其他风险警示的情况 2024 年 5 月 ...

Core Viewpoint - Shenzhen SDG Information Co., Ltd. has issued three types of corporate bonds, with a focus on improving liquidity and repaying interest-bearing debts, while facing significant financial challenges in 2024, including a decline in revenue and profit [1][5][8]. Group 1: Bond Overview - The company issued three bonds: 21 Te Xin 01 (RMB 100 million), 21 Te Xin 02 (RMB 300 million), and 21 Te Xin 03 (RMB 400 million) [1][8]. - The proceeds from 21 Te Xin 01 are intended to supplement the company's working capital, while 21 Te Xin 02 and 21 Te Xin 03 are aimed at repaying interest-bearing debts [8]. Group 2: Company Operations and Financial Status - The company operates in the optical communication industry, with four main business segments: cables, smart services, integration, and property leasing [4]. - In 2024, the company reported total assets of RMB 646,121.82 million, a decrease of 20.11% from 2023 [5]. - The company experienced a significant decline in net profit, reporting a loss of RMB 40,256.61 million, down 47.74% year-on-year, primarily due to impairment provisions related to acquisitions and market expansion challenges [5][6]. Group 3: Financial Metrics - Key financial metrics for 2024 include a current ratio of 1.33, a quick ratio of 0.99, and a debt-to-asset ratio of 68.15% [7]. - The company’s total liabilities decreased by 21.36% to RMB 440,313.40 million, while total equity fell by 17.30% to RMB 205,808.42 million [5][6]. Group 4: Debt Servicing and Management - The company has maintained a strong debt servicing capability, with a loan repayment rate and interest coverage ratio both at 100% [11]. - All bond principal and interest payments have been made on time, indicating effective management of debt obligations [11][12].

债券简称：21 特信 01 债券代码：149427.SZ 债券简称：21 特信 02 债券代码：149665.SZ 债券简称：21 特信 03 债券代码：149666.SZ 深圳市特发信息股份有限公司公司债券 2024 年定期受托管理事务报告 债券受托管理人 重点声明 根据《公司债券发行与交易管理办法》《公司债券受托管理人执业行为准则》 《深圳市特发信息股份有限公司 2021 年面向专业投资者公开发行公司债券之受 托管理协议》《深圳市特发信息股份有限公司 2021 年面向专业投资者公开发行 公司债券（第一期）募集说明书》《深圳市特发信息股份有限公司 2021 年面向 专业投资者公开发行公司债券（第二期）募集说明书》等相关规定和约定，国信 证券股份有限公司（以下简称"国信证券"）作为受托管理人，以公开信息披露 文件、发行人出具的相关说明文件以及第三方中介机构出具的专业意见等为信息 来源，编制本定期受托管理事务报告。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜作出独立判断，而不应将本报告中的任何内容据以作为国信证券所作的承诺 或声明。 2 | | | 释义 注：报告中，如部分财务数据 ...

汇宇制药：卡络磺钠注射液获药品注册证书 5月21日晚，汇宇制药（688553）发布公告称，全资子公司四川汇宇海玥医药科技有限公司收到国家药 品监督管理局核准签发的卡络磺钠注射液《药品注册证书》。该药品为化学药品3类，主要用于泌尿系 统、上消化道、呼吸道和妇产科出血疾病的治疗。此次获批视同通过仿制药质量和疗效一致性评价。 资料显示，汇宇制药成立于2010年10月，主营业务为肿瘤治疗领域药物和复杂注射剂药物的研发、生产 和国内外销售。 所属行业：医药生物–化学制药–化学制剂 百合股份：董事拟减持不超过42.4万股公司股份 5月21日晚，百合股份（603102）发布公告称，公司董事王文通计划通过集中竞价方式减持公司股份， 减持数量不超过42.4万股，占公司总股本的0.6625%。减持计划将于公告披露之日起15个交易日后的三 个月内进行。此次减持是基于王文通的个人资金需求。 资料显示，百合股份成立于2005年11月，主营业务是营养保健食品的研发、生产和销售。 所属行业：食品饮料–食品加工–保健品 金固股份：获全球龙头车企美国乘用车车轮项目定点 5月21日晚，金固股份（002488）发布公告称，公司近日收到某全球龙头车 ...